The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; CDR-Life; GlaxoSmithKline; Janssen Oncology; Novartis
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
Travel, Accommodations, Expenses - Janssen
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; K36 therapeutics; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Philippe Moreau
Honoraria - janssen celgene takeda amgen pfizer abbvie sanofi (Inst)
Consulting or Advisory Role - janssen celgene takeda amgen pfizer abbvie sanofi (Inst)
 
Manisha Bhutani
Research Funding - MedImmune, Janssen Research & Development,Bristol-Myers Squibb/Celgene, Amgen, Cerecor, Legend Biotech, Adaptive Biotechnologies, Bluebird Bio, Celularity Inc., Takeda, Caribou Biosciences (Inst)
Travel, Accommodations, Expenses - Janssen Biotech, Genzyme, Astra Zeneca
 
Albert Oriol
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Legend Biotech; Pfizer
Research Funding - AMGEN (Inst); BMSi; Janssen Oncology (Inst); Sanofi (Inst)
 
Laura Rosiñol
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst); Pfizer (Inst)
 
Rakesh Popat
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Celgene; Galapagos NV; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Johnson & Johnson/Janssen; Pfizer
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
 
Britta Besemer
Honoraria - AMGEN (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AMGEN (Inst); Janssen-Cilag
 
Joaquin Martinez-Lopez
Consulting or Advisory Role - BMS, Janssen, Roche, Novartis, Gilead, Astellas, Pfizer, Menarini
Speakers' Bureau - BMS, Janssen, Roche, Novartis, Gilead, Astellas,
Research Funding - BMS, Astellas, Janssen (Inst)
Travel, Accommodations, Expenses - BMS, Janssen, Roche, Novartis, Gilead, Pfizer, (Inst)
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; GlaxoSmithKline; Janssen Oncology; Pfizer; Regeneron; Roche; Sanofi/Aventis
Speakers' Bureau - Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Michel Delforge
Honoraria - Amgen, Janssen, BMS, Sanofi, Stemline
Consulting or Advisory Role - Amgen, BMS, Janssen, Sanofi, Stemline
Research Funding - Janssen
 
Lin Huang
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Deeksha Vishwamitra
Employment - ohnson & Johnson
Stock and Other Ownership Interests - JJ Innovative Medicine
Travel, Accommodations, Expenses - JJ Innovative Medicine (Inst)
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Katherine Chastain
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Surbhi Sidana
Consulting or Advisory Role - Magenta Therapeutics, BMS, Janssen, Sanofi, Oncopeptides, Takeda, Pfizer
Research Funding - Magenta Therapeutics, BMS, Allogene, Janssen, Novartis